• 1
  • Introduction
  • Learning Objectives
  • Etiology and Transmission
  • Pathogenesis and Clinical Manifestations
  • BCG Vaccine
  • Risk of Infection
  • Progression of Tuberculosis Infection to Disease
  • Drug-Resistant Tuberculosis
  • Summary Module 1

Treatment of Patients with Tuberculosis

• Main Menu
  • MODULE 0 - Introduction
  • MODULE 1 - Etiology and Pathogenesis of Tuberculosis
  • MODULE 2 - Diagnosis of Tuberculosis
  • MODULE 3 - Treatment of Patients with Tuberculosis
  • MODULE 4 - Special Situations
  • MODULE 5 - Adherence to Treatment
  • MODULE 6 - Patient-Physician Communication
  • MODULE 7 - Tuberculosis Infection Control

Question

Enter your response and then compare it to the correct response by clicking the Answer button.

3. In countries with high TB prevalence, BCG Vaccine is recommended for:

• a) all neonates


• b) all neonates except those who are known to be infected with HIV


• c) neonates who are at risk for TB infection


• d) all neonates except those who are at risk for TB infection